Multiplex Assay Market Revenue 2024 to 2034
Multiplex Assay Market Revenue 2024 to 2034
The global multiplex assay market size was estimated at USD 1.50 billion in 2023 and is projected to reach USD 6.75 billion by 2034, registering a CAGR of 14.79% from 2024 to 2034.
Report ID: 10168
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 1.72 Bn
Forecast Year,
USD USD 6.75 Bn
CAGR, 2025 -
14.79%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Multiplex Assay Market Size Analysis
Multiplex Assay Market Size By Type 2024 to 2034 (USD )
| Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Protein-based Multiplex Assays | 774.00 | 890.45 | 1024.41 | 1178.53 | 1355.82 | 1559.77 | 1794.39 | 2064.30 | 2374.80 | 2731.98 | 3142.87 |
| Nucleic Acid-based Multiplex Assays | 602.00 | 692.02 | 795.51 | 914.46 | 1051.20 | 1208.39 | 1389.08 | 1596.78 | 1835.54 | 2109.99 | 2425.48 |
| Cell-based Multiplex Assays | 344.00 | 391.92 | 446.48 | 508.61 | 579.36 | 659.90 | 751.60 | 855.98 | 974.81 | 1110.05 | 1263.98 |
Multiplex Assay Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Reagents & Consumables | 946.00 | 1086.90 | 1248.79 | 1434.78 | 1648.48 | 1894.00 | 2176.10 | 2500.20 | 2872.57 | 3300.40 | 3791.94 |
| Instruments & Accessories | 516.00 | 593.30 | 682.19 | 784.38 | 901.89 | 1036.99 | 1192.33 | 1370.93 | 1576.28 | 1812.39 | 2083.86 |
| Software & Services | 258.00 | 294.18 | 335.43 | 382.44 | 436.01 | 497.07 | 566.65 | 645.94 | 736.29 | 839.24 | 956.53 |
Multiplex Assay Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Companion Diagnostics | 430.00 | 494.58 | 568.87 | 654.30 | 752.57 | 865.59 | 995.57 | 1145.08 | 1317.03 | 1514.79 | 1742.24 |
| Clinical Diagnostics | 774.00 | 887.49 | 1017.61 | 1166.82 | 1337.90 | 1534.06 | 1758.98 | 2016.87 | 2312.57 | 2651.63 | 3040.39 |
| Research & Development | 516.00 | 592.32 | 679.92 | 780.48 | 895.91 | 1028.42 | 1180.52 | 1355.12 | 1555.54 | 1785.61 | 2049.70 |
Multiplex Assay Market Size By End User 2024 to 2034 (USD )
| End User | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 481.60 | 553.82 | 636.86 | 732.35 | 842.16 | 968.43 | 1113.63 | 1280.59 | 1472.58 | 1693.35 | 1947.21 |
| Clinical Laboratories | 430.00 | 494.58 | 568.87 | 654.30 | 752.57 | 865.59 | 995.57 | 1145.08 | 1317.03 | 1514.79 | 1742.24 |
| Research Institutes | 378.40 | 433.38 | 496.34 | 568.45 | 651.03 | 745.60 | 853.91 | 977.95 | 1119.99 | 1282.66 | 1468.95 |
| Pharmaceutical & Biotechnology Companies | 430.00 | 492.61 | 564.33 | 646.50 | 740.62 | 848.45 | 971.96 | 1113.46 | 1275.55 | 1461.22 | 1673.92 |
Multiplex Assay Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 688.00 | 790.54 | 908.37 | 1043.76 | 1199.33 | 1378.08 | 1583.47 | 1819.48 | 2090.65 | 2402.24 | 2760.26 |
| Asia Pacific | 447.20 | 514.92 | 592.89 | 682.66 | 786.01 | 905.01 | 1042.01 | 1199.73 | 1381.32 | 1590.38 | 1831.07 |
| Europe | 378.40 | 433.18 | 495.89 | 567.67 | 649.84 | 743.89 | 851.55 | 974.78 | 1115.84 | 1277.31 | 1462.12 |
| Latin America | 120.40 | 138.60 | 159.55 | 183.67 | 211.44 | 243.39 | 280.18 | 322.52 | 371.26 | 427.36 | 491.93 |
| Middle East and Africa | 86.00 | 97.14 | 109.69 | 123.84 | 139.76 | 157.69 | 177.87 | 200.56 | 226.07 | 254.75 | 286.96 |
Multiplex Assay Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
